NCT00237874View on ClinicalTrials.gov

Aripiprazole Treatment of Prodromal Patients

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions

SchizophreniaPsychosis

Interventions

DRUG

Aripiprazole

Trial Locations (2)

06106

Institute of Living, Hartford

06512

Yale School of Medicine, New Haven

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Yale University

OTHER